Sculptra Aesthetic Post-Approval Study
Public ClinicalTrials.gov record NCT02425943. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Open-Label, Multicenter Study to Evaluate the Long-Term Safety of Sculptra®Aesthetic in Immuno-Competent Subjects Stratified by Fitzpatrick Skin Type I-VI)
Study identification
- NCT ID
- NCT02425943
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Galderma R&D
- Industry
- Enrollment
- 867 participants
Conditions and interventions
Conditions
Interventions
- injectable poly-L-lactic acid Sculptra Aesthetic Device
Device
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 20, 2015
- Primary completion
- May 27, 2021
- Completion
- May 27, 2021
- Last update posted
- Jul 26, 2023
2015 – 2021
United States locations
- U.S. sites
- 18
- U.S. states
- 9
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Galderma Study Site | Birmingham | Alabama | 32405 | — |
| Galderma Study Site | Encino | California | 91436 | — |
| Galderma Study Site | Hermosa Beach | California | 90254 | — |
| Galderma Study Site | San Diego | California | 92121 | — |
| Galderma Study Site | Solana Beach | California | 92075 | — |
| Galderma Study Site | Aventura | Florida | 33180 | — |
| Galderma Study Site | Boca Raton | Florida | 33486 | — |
| Galderma Study Site | Coral Gables | Florida | 33146 | — |
| Galderma Study Site | Miami | Florida | 33137 | — |
| Galderma Study Site | Buffalo Grove | Illinois | 60089 | — |
| Galderma Study Site | Hackensack | New Jersey | 07601 | — |
| Galderma Study Site | New York | New York | 10016 | — |
| Galderma Study Site | White Plains | New York | 10604 | — |
| Galderma Study Site | Nashville | Tennessee | 37215 | — |
| Galderma Study Site | Austin | Texas | 78746 | — |
| Galderma Study Site | Houston | Texas | 77056 | — |
| Galderma Study Site | Plano | Texas | 75093 | — |
| Galderma Study Site | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02425943, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 26, 2023 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02425943 live on ClinicalTrials.gov.